Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vor Biopharma Inc.VOR · Entity 4763 | Chief Financial Officer | May 01, 2025 | May 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vor Biopharma Inc.
Report date May 01, 2025 · Filed May 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,280 |
Reported balance
After 2025-05-01 transaction · row 1
1 source rowRow 1 · 2025-05-01 · Tax withholding · Disposed 2,061 · Balance 51,280 F1: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2025 Filed May 2, 2025 16:30 UTC | Vor Biopharma Inc. VOR · Entity 4763 | Tax withholdingCommon Stock | 2,061 | $0.66 | $1,360.26 |
DisclosureSEC source: 0001415889-25-011824 · form4-05022025_080553.xml · nonDerivative · entry 1 Choi Han Wook · CIK 0002038629 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,280 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:19 UTC | Vor Biopharma Inc. VOR · Entity 4763 | GrantEmployee Stock Option (right to buy) · Derivative | 315,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001415889-25-003171 · form4-02062025_020247.xml · derivative · entry 2 Choi Han Wook · CIK 0002038629 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,000 Underlying: Common Stock · 315,000 shares Expires 2035-02-02 F2 · derivative.exercise_date: The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on February 1, 2025, in each case subject to the Reporting Person's continued service as of each such date. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:19 UTC | Vor Biopharma Inc. VOR · Entity 4763 | GrantCommon Stock | 52,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-003171 · form4-02062025_020247.xml · nonDerivative · entry 1 Choi Han Wook · CIK 0002038629 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,500 F1 · shares: Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest over four years in equal quarterly installments beginning on February 1, 2025, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 16:17 UTC | Vor Biopharma Inc. VOR · Entity 4763 | GrantEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001415889-24-024389 · form4-10022024_081024.xml · derivative · entry 1 Choi Han Wook · CIK 0002038629 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2034-09-29 F1 · derivative.exercise_date: 1/4th of the shares underlying the option vest on September 30, 2025, with the remainder vesting in equal monthly installments at the end of the each month thereafter over 3 years, in each case subject to the Reporting Person's continued service as of each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.